首页> 外文会议>Chinese Peptide Symposium; 20040703-06; Kunming(CN) >The study of novel peptide-based endothelin receptor antagonists
【24h】

The study of novel peptide-based endothelin receptor antagonists

机译:新型肽基内皮素受体拮抗剂的研究

获取原文
获取原文并翻译 | 示例

摘要

From the SAR studies, we concluded that the linear peptide-based ET receptor antagonists synthesized in our laboratory with following features might show high activities: (1) R group showed crucial function in improving its selectivity and affinity to ET receptor. ABO showed high ET_A receptor binding activity than others. DAD showed high hydrophilicity, that it could improve the solubility of these antagonists; (2) the first amino acid AA_1 showed high hydrophobic dependence, it was the same as the report in literature; (3) the second amino acid AA_2 can be aromatic hydrophobic amino acid. D-Trp and its derivative showed high activity in the antagonists; (4) the third amino acid AA_3 should be D-isomer, L-amino acid did not show inhibitory activity in this study.
机译:从SAR研究中,我们得出结论,在我们的实验室中合成的具有以下特征的基于线性肽的ET受体拮抗剂可能显示出高活性:(1)R基团在提高其对ET受体的选择性和亲和力方面显示出关键作用。 ABO显示出比其他更高的ET_A受体结合活性。 DAD具有很高的亲水性,可以改善这些拮抗剂的溶解性。 (2)第一个氨基酸AA_1表现出高度的疏水依赖性,与文献报道相同。 (3)第二氨基酸AA_2可以是芳族疏水氨基酸。 D-Trp及其衍生物在拮抗剂中表现出高活性; (4)第三个氨基酸AA_3应为D-异构体,L-氨基酸在本研究中未显示抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号